26 reports

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Skin Cancer
  • France
  • Germany
  • United States
  • Market Size
  • PRESCRIPTION SKIN CANCER PREPARATIONS IN DEVELOPMENT
  • 11: Prescription Skin Cancer Drugs

World Prescription Dermatological Drugs Market details the various categories of prescription dermatological drugs, describes the worldwide market for prescription dermatological drugs, and identifies major market factors that may help to shape the worldwide market for prescription dermatological drugs in the future.

  • Skin Cancer
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Skin Cancer
  • France
  • Germany
  • Italy
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • United States
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • Japan
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • United Kingdom
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • Italy
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • France
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • Germany
  • Market Size

Skin Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Skin Cancer
  • Spain
  • Market Size
  • 2.1 INTRODUCTION TO SKIN CANCER
  • 2.1 INTRODUCTION TO SKIN CANCER

Scope of the Report The report titled “Global Malignant Melanoma Market With Focus on Nevisense System: 2015-2020” provides an in-depth analysis of the global malignant melanoma market with detailed analysis of the volume of patients and deaths caused due to melanoma. The report also provides the market size of the global melanoma...

  • Skin Cancer
  • World
  • Biopharmaceuticals Inc.
  • Merck & Co., Inc.
  • Navidea Biopharmaceuticals, Inc.
  • APPENDIX: SKIN CANCER
  • TYPES AND SYMPTOMS OF SKIN CANCER

GMR Data forecasts that revenues for the dermatology drug market will reach $83.2bn in 2026. In this brand new, independently created, pharmaceutical report discover prospects for leading companies and products in the dermatology drugs market today.   5 Reasons why you must read this report today: 1. Dermatology drug...

  • Skin Cancer
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.
  • Skin Cancer Treatment Drugs Sales Volume by Type
  • CHAPTER IV SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

China’s demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Skin Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • OCT 01, 2014: VERISANTE TECHNOLOGY ANNOUNCES SUBMISSION TO THE FDA FOR AURA, A SKIN CANCER DETECTION DEVICE
  • MULTISPECTRAL IMAGING (MSI) SYSTEM - PRODUCT DESCRIPTION

Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for...

  • Skin Cancer
  • Canada
  • United States
  • GlobalData's company
  • Verisante Technology, Inc.

Global Skin Cancer Vaccine Market & Pipeline Insight 2015 ##.

  • Skin Cancer
  • Therapy
  • Vaccine
  • World
  • Forecast
  • Skin Cancer Treatment Drugs Sales Volume by Type
  • CHAPTER IV SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

This study focuses on China’s Skin Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Skin Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Market Size
  • CHAPTER III SKIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

This study focuses on China’s Skin Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Skin Cancer
  • China
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Zhejiang Expressway Co., Ltd.
  • Nonmelanomatous Skin Cancer Overview
  • Nonmelanomatous Skin Cancer - Discontinued Products

Nonmelanomatous Skin Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Nonmelanomatous Skin Cancer - Pipeline Review, H2 2015’, provides an overview of the Nonmelanomatous Skin Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nonmelanomatous...

  • Cancer
  • Skin Cancer
  • Therapy
  • Germany
  • Company Operations

Nonmelanomatous Skin Cancer - Pipeline Review, H## 2015 Table of Contents Table of Contents ## Introduction ## Global Markets Direct Report Coverage ## Nonmelanomatous Skin Cancer Overview ## Therapeutics Development ## Pipeline Products for Nonmelanomatous

  • Cancer
  • Skin Cancer
  • Therapy
  • World
  • NOV 13, 2017: MEDX HEALTH ANNOUNCES THE ADDITION OF TWO RENOWNED INTERNATIONAL SKIN CANCER SPECIALISTS TO ITS MEDICAL SCIENTIFIC ADVISORY BOARD
  • Deal Sub Type

Summary MedX Health Corp (MedX) is a medical device company that designs, manufactures and distributes phototherapeutic medical devices.The company’s phototherapy products include medx phototherapy, rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser probe,...

  • Medical Device
  • Medical Equipment
  • Skin Cancer
  • Canada
  • MedX Health Corp.
  • FEB 25, 2016: NEW TARGETED THERAPY FOR TREATMENT OF SERIOUS FORM OF SKIN CANCER APPROVED IN CANADA
  • APR 29, 2016: NICE RECOMMENDS COMBINED DRUG THERAPY PROVEN TO EXTEND LIFE FOR SKIN CANCER

Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (ERK Activator Kinase 2 or MAPK/ERK Kinase 2 or MAP2K2 or EC 2.7.12.2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (ERK Activator Kinase 2 or MAPK/ERK Kinase 2 or MAP2K2 or EC 2.7.12.2)...

  • Colorectal Cancer
  • Skin Cancer
  • Targeted Therapy
  • United States
  • Novartis AG
  • HANDHELD RCM/OCT PROBE - SKIN CANCER
  • Handheld RCM/OCT Probe - Skin Cancer - Product Status

Summary Physical Sciences Inc (PSI) is a contract research and development service provider that offers basic research and technology development applications. The company provides products such as ISR systems, laser based sensors, passive sensors and RF and optical components. It produces high gain antennas, which...

  • Microscope
  • Skin Cancer
  • United States
  • Product Initiative
  • GlobalData's company
  • Verisante Technology Inc - Company Statement
  • Name

Verisante Technology Inc (VRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and...

  • Skin Cancer
  • United States
  • World
  • Company Financials
  • Verisante Technology, Inc.
  • APR 29, 2016: NICE RECOMMENDS COMBINED DRUG THERAPY PROVEN TO EXTEND LIFE FOR SKIN CANCER
  • FEB 25, 2016: NEW TARGETED THERAPY FOR TREATMENT OF SERIOUS FORM OF SKIN CANCER APPROVED IN CANADA

Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2)...

  • Cancer
  • Skin Cancer
  • United States
  • Product Initiative
  • Novartis AG
  • Clinical Trial profile. 108 Trial Title
  • Therapy Area Indication(s)

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2017" provides an overview of Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials scenario. This report...

  • Cancer
  • Skin Cancer
  • Therapy
  • World
  • Product Initiative
  • SKIN CANCER IHC DIAGNOSTIC TEST - PRODUCT STATUS
  • MAGE-A3 SKIN CANCER ASSAY - PRODUCT DESCRIPTION

Melanoma - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Melanoma - Pipeline Review, 2015" provides an overview of Melanoma diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products...

  • Biomarker
  • Skin Cancer
  • United States
  • Company
  • GlobalData's company